Epidemiological and microbiological characteristics of an outbreak 1. caused by OXA-48-producing Enterobacteriaceae in a neonatal 2
|
|
- Oswald Arnold
- 6 years ago
- Views:
Transcription
1 JCM Accepts, published online ahead of print on 26 June 2013 J. Clin. Microbiol. doi: /jcm Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Epidemiological and microbiological characteristics of an outbreak 1 caused by OXA-48-producing Enterobacteriaceae in a neonatal 2 intensive care unit in Jerusalem 3 4 Amos Adler 1^*, Ester Solter 1^, Samira Masarwa 1, Tamar Miller-Roll 1, Bassam 5 Abu-Libdeh 2, Hatem Khammash 2, Khalil Najem 2, Susan Dekadek 2, Chen Stein- 6 Zamir 3, Nafez Nubani 3, Amin Kunbar 3, Marc Victor Assous 4, Yehuda Carmeli 1 7 and Mitchell J. Schwaber National Center for Infection Control, Ministry of Health, Tel-Aviv Makassed Hospital, Jerusalem Jerusalem District Health Office, Ministry of Health, Jerusalem Shaare-Zedek Medical Center, Microbiology and Immunology Laboratory, 13 Jerusalem, Israel ^Both authors contributed equally to the study Running title: OXA-48 producing Enterobacteriaceae outbreak in a NICU *Corresponding author: Amos Adler 20 Tel-Aviv Sourasky Medical Center 21 6 Weizmann St., Tel-Aviv, Israel 22 Tel: , fax: amosa@tlvmc.gov.il 24 25
2 2 Abstract 1 This study describes the course of an OXA-48-producing Enterobacteriaceae (OPE) 2 outbreak that started in March 2012 in a neonatal intensive care unit (NICU) in 3 Jerusalem. During the peak of the outbreak (January-August 2012), there were 49 4 patients who had proven or suspected acquisition of OPE in the NICU, including 16 5 with invasive infections, out of a total of 156 patients hospitalized during that period. 6 Three children hospitalized in the Pediatric ICU were identified as carriers of OPE. 7 Three patients with a previous stay in the affected NICU were identified as OPE 8 carriers upon admission to another hospital. The Ministry of Health was notified and 9 intervened in July The intervention included cohorting colonized patients, 10 frequent rectal surveillance and improving the implementation of infection control 11 practices. As a result, the incidence of OPE acquisition declined to 5 cases in the first 12 4 months with no new cases in the following 3 months. 31 patient-unique isolates 13 were available for analysis: 29 K. pneumoniae isolates, all belonging to a single clone 14 (ST39), and 2 isolates of Enterobacter cloacae. All isolates possessed bla OXA-48 and 15 bla CTX-M-14, located on the same plasmid. This plasmid, similar to the global bla OXA harboring vector, has now acquired bla CTX-M-14, leading to resistance to all β-lactam 17 agents
3 3 Introduction 1 The OXA-48 carbapenemase was first discovered in various Enterobacteriaceae 2 species isolated in Turkey and other countries in the Middle-East (5). Within years, 3 several sporadic cases of OXA-48 producing Enterobacteriaceae (OPE) infections 4 have been reported from across Europe. Most of these cases were related to patients 5 with previous exposure to healthcare systems in the Middle East and North Africa 6 (25). In Israel, the first cases of OPE were described in patients coming from the 7 Palestinian Authority (PA) or from neighboring countries (3). As KPC-producing 8 Enterobacteriaceae were already endemic in Israel at that time (23), OPE were 9 suspected based on their susceptibility to 3 rd -generation cephalosporins, a unique 10 feature of OPE (19). Another unique feature of OPE in Israel and worldwide, is the 11 location of bla OXA-48 inside a Tn1999 transposon, harbored by a unique, 62 kb IncL/M 12 plasmid, that is capable of self inter-species conjugation (3, 18). In recent years, 13 outbreaks of OPE were reported from several European countries (8, 16, 20, 26). 14 These outbreaks were caused mainly by monoclonal spread of K. pneumoniae strains 15 that co-produced CTX-M-15, conferring resistance also to all cephalosporins. bla CTX- 16 M-15 was located on a separate plasmid in the outbreak isolates; it was found inside the 17 same transposon in a single case report (21). All of these outbreaks, as well as other 18 sporadic cases, were reported in adults only. In the present study, we describe the first 19 case of a large-scale OPE outbreak in a Neonatal Intensive Care Unit (NICU), the 20 intervention and its results. The outbreak was propagated by a combination of both 21 monoclonal spread of a single K. pneumoniae strain and by horizontal transfer of the 22 modified bla OXA-48 -harboring plasmid, co-carrying the bla CTX-M-14 gene
4 4 Methods 1 Setup and design 2 Makassed Hospital (MH) is a 250-bed hospital, affiliated with the School of Medicine 3 of Al-Quds University and representing its main teaching hospital. Located in East 4 Jerusalem, it provides secondary and tertiary medical services for the local Palestinian 5 population, and functions as a referral center for patients from the Palestinian 6 Authority and the Gaza Strip. The Neonatal Intensive Care Unit (NICU) is a 27-bed 7 unit, caring for premature (including very-low birthweight babies) and sick babies 8 who were born there or transferred from other hospitals in the Palestinian territories. It 9 contains intensive care (15 beds) and intermediate care (12 beds) sections. 10 The intervention team of the Israeli Ministry of Health (MoH) was composed of 11 personnel from the offices of the National Center for Infection Control (NCIC) and 12 the Jerusalem District Health Office (JDHO). Data were collected prospectively from 13 the initiation of the intervention (June 2012) and retrospectively from that point back 14 to the time the first cases were identified (March 2012). 15 General overview of the OPE outbreak and Infection control practices at Makassed 16 Hospital 17 Prior to the OPE outbreak, infection control practices that included hand hygiene and 18 isolation procedures were implemented in the NICU and throughout the hospital, but 19 with suboptimal compliance. Surveillance for carbapenem-resistant 20 Enterobacteriaceae (CRE) was performed on admission in all high-risk patients 21 (defined as patients either being transferred from another medical center or arriving 22 from the Palestinian territories) and as part of contact investigation. 23 The OPE NICU outbreak lasted from March 2012 with the last case of OPE carriage 24 identified in December 2012, resulting in a total of 57 affected patients, including 16 25
5 5 with invasive infections. Aside from this outbreak, the incidence of CRE at MH 1 during this period was low - between July 2012 until April 2013, 5 new cases were 2 identified upon admission and only one case was detected in a hospitalized patient. 3 Rectal carbapenem-resistant Enterobacteriaceae surveillance cultures and 4 phenotypic characterization of isolates 5 MH lab: Rectal CRE surveillance culture swabs were streaked onto MacConkey agar 6 plates supplemented with either cefotaxime (10 mg/l) or meropenem (0.5 mg/l), per 7 local protocol. Pink colonies growing around the disks were picked and processed. 8 Bacterial identification was done by manual biochemical tests and antimicrobial 9 susceptibility testing was done by disk diffusion (7). Complete phenotypic and 10 molecular characterization was performed by the NCIC lab on available isolates as 11 part of the investigation but was not available before the intervention. 12 NCIC lab: Rectal CRE surveillance cultures were transported within 4 h to the NCIC 13 lab. Swabs were inoculated into BHI broth and incubated overnight prior to subculture 14 onto MacConkey agar with imipenem 1mg/L (4). Suspicious (pink) colonies were 15 selected for further evaluation. Identification and antimicrobial susceptibility testing 16 were performed by the VITEK-2 system (biomérieux, Marcy l Etoile, France). 17 Ertapenem, imipenem and meropenem MIC were verified by the agar dilution assay 18 (6). Phenotypic characterization included the modified Hodge test (MHT), and 19 synergy testing of ertapenem with and without EDTA (EDTAST).(10) 20 Molecular characterization of isolates 21 Isolates were screened by PCR for bla KPC,(22) bla NDM-1 and bla OXA-48 (19). bla CTX-M, 22 bla TEM and bla SHV were identified by PCR and sequencing (14, 26). Pulsed-field gel 23 electrophoresis (PFGE) was performed for K. pneumoniae and Enterobacter cloacae 24 isolates as previously described (12). Multi-locus sequence typing (MLST) was 25
6 6 performed for representative PFGE types of the K. pneumoniae (9) isolates. Since 1 only 29/57 patient-unique isolates were available for molecular and phenotypic 2 analyses (from the latter part of the outbreak), we referred to the isolates as either 3 OPE or CRE, depending on whether full characterization was done or not, 4 respectively. 5 Plasmid analysis 6 Plasmid DNA, purified from a representative K. pneumoniae isolate and the 2 E. 7 cloacae isolates, was transformed into E. coli DH10B. Transformants were selected 8 on LB agar supplemented with cefazolin (8 mg/l) and confirmed by bla OXA-48 -PCR. 9 Determination of plasmid size and restriction-fragment length polymorphism (RFLP) 10 were done as previously described (11). The genetic environment of bla OXA-48 was 11 studied by PCR and sequencing (5). The presence of the repa, para and trau was 12 tested by PCR (18). The genetic environments up- and downstream to bla CTX-M were studied by sequencing of the bla OXA-48 /bla CTX-M-14 -carrying plasmid, using 14 primers directed to the 5' and 3' ends of bla CTX-M-14, respectively. The sequence was 15 analyzed using the ISfinder website ( (24) Results 18 Epidemiological features of the outbreak 19 The first clinical cases of CRE in the NICU were noted in mid-march, Two 20 babies had CRE bacteremia, one with Klebsiella spp. and one with Serratia 21 marcescens, in both cases more than 72 hours from admission. In the second case, the 22 baby was admitted flowing a short stay in a Palestinian Authority hospital. 23 Subsequently, Klebsiella spp. were isolated in CRE surveillance cultures in 6 babies. 24 In the following 17 weeks, until the beginning of the NCIC intervention, 27 new cases 25
7 7 were identified (figure 1a: cases identified in the MH NICU are marked in grey, and 1 cases identified in other MH wards and additional hospitals are marked in black), with 2 incidence reaching 9 cases/week. All isolates were identified as either Klebsiella spp. 3 or K. pneumoniae, except for 1 isolate of E. coli and 2 of Enterobacter cloacae (see 4 text below and table 1). 5 Intervention and outcome 6 The NCIC and the JDHO were notified in early July 2012, and an intervention was 7 launched. The measures taken included: a) cohorting of colonized patients in a 8 completely separate, interim location, with complete separation of staff and 9 equipment from the unaffected babies; b) closing the NICU to new admissions (this 10 was done for 3 weeks); c) reinforcement of infection control practices (including hand 11 hygiene, equipment and environmental cleaning, injection safety, standard and 12 isolation precautions); d) frequent rectal surveillance cultures of all CRE-negative 13 babies in the NICU (at least once a week); e) CRE surveillance of exposed patients 14 hospitalized in other pediatric wards in the hospital; f) CRE surveillance and close 15 monitoring of admissions of exposed infants to other hospitals (via the MoH reporting 16 system) and g) submission of all available CRE isolates for molecular studies at the 17 NCIC lab. Implementation of the intervention was overseen in frequent site visits to 18 the hospital undertaken by staff of the NCIC and JDHO. Surveillance of hospital staff 19 and the mothers of the NICU babies were not performed as colonization among them 20 was not believed to be related to the propagation of the outbreak. 21 During the first week of the intervention, 8 new cases were identified in the NICU 22 (surveillance-7, clinical-1). Two additional new carriers were identified in the next 23 month, all previously exposed (figure 1a). The NICU was re-opened for new 24 admissions after 3 weeks with the previously identified carriers cohorted in a separate 25
8 8 location. A previously exposed infant readmitted to the Pediatric Intensive Care unit 1 was found to be a carrier of OXA-48-producing K. pneumoniae, and a survey of that 2 unit identified 2 additional carriers, with the infant presumably serving as the index 3 case in that unit. Three previously-exposed infants admitted to another hospital were 4 found to be carriers of OPE (figure 1b: black and grey circles represent acquisition of 5 OPE during or after the initial NICU outbreak ( ), respectively; a dashed 6 arrow represents home stay prior to re-admission). During the peak of the outbreak 7 (January-August 2012), 49 patients were identified with proven or suspected 8 acquisition of OPE in the NICU, out of a total of 156 patients hospitalized in the 9 NICU during that period (31%). Invasive infections (blood and/or CSF) were detected 10 in 16 patients and 4 of these patients died within 14 days of isolation of the pathogen. 11 One patient carrying the outbreak K. pneumoniae clone, with no known exposure to 12 other carriers or core staff members (i.e., nurses and physicians), was identified in the 13 Pediatrics ward. Following the re-opening of the NICU, 5 additional patients carrying 14 the epidemic K. pneumoniae clone were identified (figure 1b). Additional site visits 15 by the MoH teams were conducted and these patients were cohorted in separate rooms 16 with dedicated nursing staff. Weekly CRE surveillance was continued in the NICU 17 until present with no new cases of OPE identified. 18 In addition to the OPE outbreak in the NICU, 5 additional isolates of carbapenem- 19 resistant K. pneumoniae were detected in the Pediatrics ward and the PICU of MH: 3 20 isolates of OPE were detected by surveillance culture upon admission from Gaza and 21 the PA, all presenting different PFGE patterns than that of the epidemic strain (data 22 not shown); 1 isolate of KPC-producing K. pneumoniae was detected by surveillance 23 culture upon admission to the PICU of a patient transferred from a hospital in central 24 Israel; an additional isolate was later discovered in another patient in that unit. 25
9 9 Microbiological and molecular features of OXA-48-producing Enterobacteriaceae 1 isolates 2 A total of 31 outbreak-related isolates from 29 patients were submitted for analysis to 3 the NCIC laboratory. K. pneumoniae was isolated from all patients, and all isolates 4 belonged to a single PFGE type, identified as ST39 (table 1). Two patients also 5 carried OXA-48 producing E. cloacae, belonging to two different PFGE types. All 6 isolates were resistant to ampicillin, cefazolin, piperacillin-tazobactam, ceftriaxone 7 and ertapenem, but had MIC values below 1 mg/l for imipenem and meropenem 8 (table 1). The E. coli DH10B transformant isolates from both the K. pneumoniae and 9 E. cloacae donor strains had similar resistance patterns for carbapenems and were also 10 resistant to ampicillin, cefazolin, piperacillin-tazobactam and ceftriaxone but not to 11 any other class of antimicrobials. All isolates tested positive by MHT and carried 12 bla OXA-48 and bla CTX-14 ; they tested negative by the EDTAST, bla KPC and bla NDM PCR. 13 The K. pneumoniae isolates also carried bla CTX-15, bla TEM-1 and bla SHV-1. The bla OXA harboring plasmids were ~62 kb in size and carried the repa, para and trau genes, as 15 did our previously described bla OXA-48 -harboring plasmids (3). Unlike these plasmids, 16 they also carried bla CTX-14 and had an identical restriction-fragment length 17 polymorphism pattern that differed from the pattern(s) of these plasmids (data not 18 shown). bla CTX-14 was surrounded by ISEcp1 (AJ242809) (figure 2). The entire 3.1 kb 19 structure was inserted in position 26950, corresponding to the poxa-48a plasmid 20 (JN ) (18) Discussion 23 In the present study, we describe the first case of OPE in the Neonatal and Pediatric 24 population. Moreover, this is the first report of an outbreak caused by CRE of any 25
10 10 kind in this population. This population has not been spared nosocomial outbreaks 1 caused by other types of antimicrobial-resistant bacteria, e.g., extended-spectrum β- 2 lactamase producing Enterobacteriaceae (17), corresponding with the occurrence in 3 other patient populations. It is noteworthy however, that although sporadic cases of 4 OPE in adults have been described in Israel (3), the first and so far the only OPE 5 outbreak in Israel occurred in the pediatric population. The data regarding the 6 prevalence of OPE in the PA and Gaza are limited, but based on this study and our 7 previous report (3), it appears likely that OPE are endemic in these areas, similar to 8 the situation in other Middle-Eastern countries (5, 14). 9 Due to the fact that several months elapsed between the onset of the outbreak and the 10 involvement of the MoH, we were unable to obtain the microbiological data necessary 11 to determine its origin. During the investigation of this outbreak we identified carriers 12 of additional, unrelated OPE who were admitted to other pediatric services from the 13 PA or Gaza. It is therefore likely that the outbreak strain was introduced in a similar 14 way, following an admission of an unrecognized carrier, either directly to the NICU 15 or to one of the other pediatric services. The monoclonal nature of the outbreak and 16 the spread of the outbreak strain to other ward lead to the conclusion that although 17 initial introduction of the strain via maternal carriage could not be excluded, this 18 mechanism is unlikely to have played a role in the subsequent propagation of the 19 outbreak. 20 The epidemic strain presumably spread initially in the NICU, leading to colonization 21 of at least 49 patients with 16 invasive infections. From there, we were able to trace 22 its spread to the PICU following the re-admission of a former NICU-exposed baby 23 that led to transmission of the strain to two additional children. Following the 24 intervention, the incidence of new colonization or infection significantly declined. 25
11 11 However, despite the cohorting of the OPE carriers and the allocation of a dedicated 1 nursing staff to care for them, the epidemic strain re-appeared in the re-opened NICU, 2 presumably due to a single exposed infant who had previously tested negative, who 3 transmitted the strain to 4 additional infants. The strain was also detected in one 4 patient in the Pediatrics ward not known to be exposed to any of the carriers (figure 5 1b), suggesting transmission via either contaminated equipment or other hospital staff. 6 Surveillance of OPE colonization among hospital staff was not performed as staff 7 carriage has not been shown to be an important factor in nosocomial transmission of 8 multi-drug-resistant Enterobacteriaceae (1). Indeed, implementation of proper 9 infection control policies, including hand hygiene and ongoing surveillance of patients 10 at risk, proved to be sufficient to contain the resurgence of the outbreak. 11 One of the dreaded threats to public health in any local outbreak is its potential to 12 spread via unrecognized carriers to other healthcare centers (13). The establishment of 13 our nationally-coordinated registry of CRE (23) enabled us to alert and communicate 14 with the neighboring hospitals, allowing detection of carriers upon admission and 15 their prompt isolation, resulting in outbreak containment. 16 Similar to previous reports from Europe [7-10], the main mechanism of this outbreak 17 was monoclonal spread of K. pneumoniae. The epidemic clone, ST-39, was 18 previously reported as a VIM-producing strain in a nosocomial outbreak in Spain 19 [26], but has never been associated with OPE outbreaks. In addition, we identified 20 two cases of presumed horizontal plasmid transfer in two patients, who carried OXA producing E. cloacae in addition to the epidemic strain. The bla OXA-48 -harboring 22 plasmid in these isolates was similar in size to the poxa-48a plasmid and possessed 23 its characteristic genes (18), but differed from it by the presence of bla CTX-M-14 carried 24 along the ISEcp1 transposon. Although additional β-lactamase-encoding genes, 25
12 12 including bla CTX-M-15, were also present in the outbreak strain as in previous reports 1 (26), this is only the second report describing the integration of an additional 2 resistance gene into the poxa-48a plasmid (21). This unique characteristic allowed 3 us to track the route of horizontal plasmid transfer and to differentiate the outbreak 4 strain from non-related OPE strains that were introduced to the hospital during the 5 outbreak. The addition of another resistance element to this plasmid is an ominous 6 finding due to the plasmid's demonstrated high degree of transmissibility (3, 5); the 7 added resistance gene in this case renders all recipient strains resistant to 8 cephalosporins, thus limiting therapeutic options even further. 9 In conclusion, the study of this outbreak teaches us that while standard infection 10 control measures are effective for initial containment, continuous vigilant monitoring 11 is essential in order to detect and respond to a subsequent resurgence. It also 12 demonstrates the value of a centralized coordinating body, allowing for prompt 13 identification of unidentified carriers on admission to other hospitals. In areas where 14 CRE of various types are endemic, a thorough molecular analysis that includes 15 identification of resistance genes, clones and plasmids is of paramount importance in 16 an outbreak setting for accurate assessment of the outbreak's course, containment and, 17 should it occur, resurgence
13 13 Figure 1. Temporal and spatial analysis of the OXA-48 producing 1 Enterobacteriaceae (OPE) outbreak in the NICU. A. Incidence of suspected and 2 proven OPE infections (surveillance and clinical cultures). Cases initially identified in 3 the MH NICU (grey lines), other MH wards and additional hospital (black lines) are 4 included. B. Spatial dissemination of the OPE outbreak outside the NICU. OPE 5 outbreak was ongoing in the NICU from March 2012 until July 2012 (solid line); the 6 NICU was opened to new admissions only, after 3 weeks (dashed line). Filled and 7 empty black circles represent acquisition of OPE during the initial NICU outbreak ( ), with first detection during or following NICU stay, respectively. Grey circles 9 represent acquisition of OPE outside of the initial NICU outbreak. A dashed arrow 10 represents home stay prior to re-admission. A solid arrow represents transmission of 11 the outbreak strain Figure 2. Schematic structure of the bla CTXM-14 -containing insert. The orientation 14 of the insert is presented in relation to the poxa-48a plasmid (JN )
14 14 References 1 1. A. Adler, M. Gniadkowski, A. Baraniak, R. Izdebski, J. Fiett, A. Salvia, 2 J.V. Samso, C. Lawrence, J. Salomon, M. Paul, Y. Schwartzberg, E. 3 Mordechai, A. Rossini, J. Fierro, C. Lammens, S. Malhotra-Kumar, H. 4 Goossens, W. Hryniewicz, C. Brun-Buisson YC A multinational study 5 of colonisation with extended-spectrum beta-lactamases (ESBL)-producing 6 Enterobacteriaceae in HCW and family members of patients admitted to 7 rehabilitation centres. 23rd European Congress of Clinical Microbiology and 8 Infectious Diseases (ECCMID). Berlin A. Valverde, P. Ruiz-Garbajosa, T. Curiao, M. Tato, D. Gijón, F. Baquero, 10 T.M. Coque RC Klebsiella pneumoniae sequence types originally 11 associated with specific ESBLs might act as substrates for recently emerged 12 metallo-beta-lactamases or KPC enzymes.21st European Congress of Clinical 13 Microbiology and Infectious Diseases (ECCMID). Milan Adler a., Shklyar M, Schwaber MJ, Navon-Venezia S, Dhaher Y, Edgar R, 15 Solter E, Benenson S, Masarwa S, Carmeli Y Introduction of OXA producing Enterobacteriaceae to Israeli hospitals by medical tourism. 17 Journal of Antimicrobial Chemotherapy 66: Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, 19 Carmeli Y Laboratory and clinical evaluation of screening agar plates 20 for detection of carbapenem-resistant enterobacteriaceae from surveillance 21 rectal swabs. Journal of clinical microbiology 49: Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, Matar G, 23 Honderlick P, Nordmann P Spread of OXA-48-encoding plasmid in 24 Turkey and beyond. Antimicrobial agents and chemotherapy 54: Clinical and Laboratory Standards Institute Methods for Dilution 26 Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically ; 27 Approved Standard Ninth Edition. Clinical and Laboratory Standards 28 Institute, Wayne, PA Clinical and Laboratory Standards Institute Performance Standards 30 for Antimicrobial Susceptibility Testing; Twenty-First Informational 31 Supplement. Approved standard MS100-S20. Clinical and Laboratory 32 Standards Institute, Wayne, PA Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P Outbreak of 34 OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in 35 France. Antimicrobial agents and chemotherapy 55: Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S Multilocus 37 sequence typing of Klebsiella pneumoniae nosocomial isolates. Journal of 38 clinical microbiology 43:
15 Giske CG, Gezelius L, Samuelsen Ø, Warner M, Sundsfjord A, Woodford 1 N A sensitive and specific phenotypic assay for detection of metallo-β- 2 lactamases and KPC in Klebsiella pneumoniae with the use of meropenem 3 disks supplemented with aminophenylboronic acid, dipicolinic acid and 4 cloxacillin. Clinical microbiology and infection 17: Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, 6 Navon-Venezia S Transfer of carbapenem-resistant plasmid from 7 Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerging 8 infectious diseases 16: Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia 10 S Molecular epidemiology, sequence types, and plasmid analyses of 11 KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrobial agents 12 and chemotherapy 54: Lopez J a, Correa a, Navon-Venezia S, Correa a L, Torres J a, Briceño 14 DF, Montealegre MC, Quinn JP, Carmeli Y, Villegas M V Intercontinental spread from Israel to Colombia of a KPC-3-producing 16 Klebsiella pneumoniae strain. Clinical microbiology and infection : the official 17 publication of the European Society of Clinical Microbiology and Infectious 18 Diseases 17: Matar GM, Dandache I, Carrër A, Khairallah M-T, Nordmann P, Sabra 20 A, Araj GF Spread of OXA-48-mediated resistance to carbapenems in 21 Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended 22 spectrum beta-lactamase. Annals of tropical medicine and parasitology : Navon-Venezia S, Chmelnitsky I, Leavitt A, Carmeli Y Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella 26 pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the 27 novel enzyme CTX-M-41 in Proteus mirabilis in Israel. The Journal of 28 antimicrobial chemotherapy 62: Paño-Pardo JR, Ruiz-Carrascoso G, Navarro-San Francisco C, Gómez-Gil 30 R, Mora-Rillo M, Romero-Gómez MP, Fernández-Romero N, García- 31 Rodríguez J, Pérez-Blanco V, Moreno-Ramos F, Mingorance J Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary 33 hospital in Spain in the setting of a prolonged, hospital-wide outbreak. The 34 Journal of antimicrobial chemotherapy 68: Paterson DL, Bonomo RA Extended-spectrum beta-lactamases: a 36 clinical update. Clinical microbiology reviews 18: Poirel L, Bonnin R a, Nordmann P Genetic features of the widespread 38 plasmid coding for the carbapenemase OXA-48. Antimicrobial agents and 39 chemotherapy 56:
16 Poirel L, He C, Tolu V, Nordmann P Emergence of Oxacillinase- 1 Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrobial 2 agents and chemotherapy 48: Potron A, Kalpoe J, Poirel L, Nordmann P European dissemination of 4 a single OXA-48-producing Klebsiella pneumoniae clone. Clinical 5 microbiology and infection : the official publication of the European Society of 6 Clinical Microbiology and Infectious Diseases 17:E Potron A, Nordmann P, Rondinaud E, Jaureguy F, Poirel L A 8 mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance. 9 The Journal of antimicrobial chemotherapy 68: Schechner V, Straus-Robinson K, Schwartz D, Pfeffer I, Tarabeia J, 11 Moskovich R, Chmelnitsky I, Schwaber MJ, Carmeli Y, Navon-Venezia S Evaluation of PCR-based testing for surveillance of KPC-producing 13 carbapenem-resistant members of the Enterobacteriaceae family. Journal of 14 clinical microbiology 47: Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, Shalit 16 I, Carmeli Y Containment of a country-wide outbreak of carbapenem- 17 resistant Klebsiella pneumoniae in Israeli hospitals via a nationally 18 implemented intervention. Clinical infectious diseases 52: Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M ISfinder: 20 the reference centre for bacterial insertion sequences. Nucleic acids research 21 34:D Tzouvelekis LS, Markogiannakis a., Psichogiou M, Tassios PT, Daikos GL Carbapenemases in Klebsiella pneumoniae and Other 24 Enterobacteriaceae: an Evolving Crisis of Global Dimensions. Clinical 25 Microbiology Reviews 25: Voulgari E, Zarkotou O, Ranellou K, Karageorgopoulos DE, Vrioni G, 27 Mamali V, Themeli-Digalaki K, Tsakris A Outbreak of OXA carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 29 clone. The Journal of antimicrobial chemotherapy 68: Woodford N, Fagan EJ, Ellington MJ Multiplex PCR for rapid 31 detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. The 32 Journal of antimicrobial chemotherapy 57:
17 Table 1. Microbiological and molecular characteristics of OXA-48 producing Enterobacteriaceae isolates. Variable K. pneumoniae E. cloacae No. of isolates 29 2 Source 1 B-4, S-1, R-24 R Strains 2, no. 1 (ST39) 2 β-lactamase-encoding genes Ertapenem MIC, mg/l (median, range) Imipenem MIC, mg/l (median, range) Meropenem MIC, mg/l (median, range) bla OXA-48, -CTX-M-14, -CTX-M- bla OXA-48, -CTX-M-14 15, TEM-1, SHV-1 2, 2->16 3, , 0.25->8 0.75, , 0.25->8 0.5, bla OXA-48 plasmid, kb ~62 ~62 bla OXA-48 plasmid, genes bla CTX-M-14, repa, para, trau bla CTX-M-14, repa, para, trau Tn1999 type source: B-blood, S-sputum, R-rectal; 2 -typing was done by PFGE and MLST for K. pneumoniae and by PFGE for E. cloacae.
18
19
20
Screening and detection of carbapenemases
Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated
More informationGuidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011
Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review
More informationRevised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in
AAC Accepts, published online ahead of print on 3 December 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01180-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More information#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore
AAC Accepts, published online ahead of print on 21 October 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01754-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Title: Escherichia
More informationGlobal Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE)
Global Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE) Mitchell J. Schwaber, MD MSc Director, National Center for Infection Control Ministry of Health State of Israel November 27, 2012 1
More informationLaboratory testing for carbapenems resistant Enterobacteriacae (CRE)
Laboratory testing for carbapenems resistant Enterobacteriacae (CRE) Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Senior lecturer WITS, 9 th March 2013
More informationRecommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals
Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals Minnesota Department of Health 11/2011 Infectious Disease Epidemiology,
More informationCarbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School
Carbapenemases in Enterobacteriaceae: 2012 Prof P. Nordmann Bicêtre hospital, South-Paris Med School March 21, 2012 Trends in Molecular Medecine NDM IMP OXA-48 KPC VIM ALERT VI M KPC KPC NDM I MP OXA-
More informationALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella
ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa
More informationDetermining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing
AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the
More informationMolecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2010, p. 3002 3006 Vol. 54, No. 7 0066-4804/10/$12.00 doi:10.1128/aac.01818-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Molecular
More informationST11 KPC-2 Klebsiella pneumoniae detected in Taiwan
AAC Accepts, published online ahead of print on 30 January 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.05576-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5
More informationDetection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 5 (2016) pp. 864-869 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.505.089
More informationKPC around the world Maria Virginia Villegas, MD, MSC
KPC around the world Maria Virginia Villegas, MD, MSC Scientific Director Bacterial Resistance and Nosocomial Infections Research Area International Center for Medical Research and Training, CIDEIM, Cali,
More informationDevelopment of a phenotypic method for fecal carriage detection of OXA-48-producing
JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00055-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationEducational Workshops 2016
Educational Workshops 2016 Keynote CPE Screening We are grateful to Dr Andrew Dodgson, Consultant Microbiologist, Public Health England and Central Manchester Hospitals NHS Foundation Trust Terminology
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known
More informationSensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase
JCM Accepts, published online ahead of print on 19 October 2011 J. Clin. Microbiol. doi:10.1128/jcm.05602-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationRegional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA)
National Center for Emerging and Zoonotic Infectious Diseases Regional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA) Chris Prestel, MD Epidemic Intelligence Service
More informationCombined disk methods for the detection of KPC- and/or VIM-positive. Klebsiella pneumoniae: improving reliability for the double carbapenemase
Received Date : 27-Dec-2012 Revised Date : 30-Mar-2013 Accepted Date : 31-Mar-2013 Article type : Research Note - online only Combined disk methods for the detection of KPC- and/or VIM-positive Klebsiella
More informationDiscussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category
Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide
More informationEnterobacteriaceae? ECDC EVIDENCE BRIEF. Why focus on. Update on the spread of carbapenemase-producing Enterobacteriaceae in Europe
ECDC EVIDENCE BRIEF November 2015 Update on the spread of carbapenemase-producing Enterobacteriaceae in Europe Summary of the May 2015 expert assessment The EuSCAPE project This ECDC Evidence Brief identifies
More informationIn-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342
More informationPublic Health Surveillance for Multi Drug Resistant Organisms in Orange County
Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action
More informationPrevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
More informationReceived 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011
JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1965 1969 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.00203-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Comparative
More informationFirst Clinical Cases of OXA-48 Producing Carbapenem Resistant Klebsiella pneumoniae in
JCM Accepts, published online ahead of print on 21 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02580-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10
More informationDifferentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test
Original article: Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Manish Bansal 1, Nitya Vyas 2, Babita Sharma 3, R.K.Maheshwari 4 1PG Resident, 2 Professor, 3 Assistant
More informationTHE INVASION BY CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE
ANKEM Derg 2012;26(Ek 2):31-35 THE INVASION BY CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE Patrice NORDMANN Service de Bactériologie-Virologie, Hôpital de Bicêtre, Le Kremlin-Bicêtre, South-Paris Medical
More informationEmergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH
Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.
More informationTitle: Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-
AAC Accepts, published online ahead of print on 7 May 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.00638-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Title: Detection
More informationEmergence of non-kpc carbapenemases: NDM and more
Emergence of non-kpc carbapenemases: NDM and more --- David Livermore Health Protection Agency, UK The first acquired carbapenemase to be recognised in gram-negative bacteria was IMP-1, a metallo-type,
More informationHOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION
Appendix 1: Carbapenem-Resistant Enterobacteriacaea (CRE) I. Definition: 2015 CDC definition of CRE are Enterobacteriaceae 1 that are: A. Resistant to any carbapenem antimicrobial (i.e., minimum inhibitory
More informationDetecting CRE. what does one need to do?
5 th ICAN Conference, Harare 4 th November 2014 Room 2: 10:30-12:00 Detecting CRE (Carbapenem-resistant Enterobacteriaceae) what does one need to do? Dr Nizam Damani Associate Medical Director Infection
More informationThe Public Health Benefit of CRE Colonization Testing
The Public Health Benefit of CRE Colonization Testing Allison C Brown, PhD MPH Team Lead, AR Capacities and Special Studies Division of Healthcare Quality Promotion CDC Carbapenem Resistance Serious threat
More informationGuidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Produc... Producing Enterobacteriaceae in Acute Care Facilities
Page 1 of 6 Weekly March 20, 2009 / 58(10);256-260 Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase- Producing Enterobacteriaceae in Acute Care Facilities Infection with carbapenem-resistant
More informationCarbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.
JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks
More informationCarbapenems and Enterobacteriaceae
Title Carbapenems and Enterobacteriaceae Presenter s details NHLS Dr Khine Swe Swe/Han FC Path ( Micro), SA MMed( micro), SA DTMH(Wits univ),sa PDIC(Stellen univ)sa MB,BS(Yangon),Myanmar Pathologist,Consultant/Lecturer,
More informationCarbapenemase Producing Enterobacteriaceae: Screening
Carbapenemase Producing Enterobacteriaceae: Screening Dr David Harvey Consultant Microbiology and Infection Prevention and Control Nov 2015 Aims Is CPE a problem? Does screening have the potential to help?
More informationAbstract. Introduction. Methods. Editor: R. Canton
ORIGINAL ARTICLE BACTERIOLOGY High rate of faecal carriage of extended-spectrum b-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a University hospital in Morocco D. Girlich 1, N. Bouihat
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.
Annual survey of extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae, 2013 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research
More informationScottish Microbiology and Virology Network. Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service
Scottish Microbiology and Virology Network Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service Total number of carbapenemase producing organisms isolated
More informationMulticlonal dispersal of KPC genes following the emergence of non-st258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain
J Antimicrob Chemother 2013; 68: 2487 2492 doi:10.1093/jac/dkt237 Advance Access publication 20 June 2013 Multiclonal dispersal of KPC genes following the emergence of non-st258 KPC-producing Klebsiella
More informationInternational transfer of NDM-1-producing Klebsiella. pneumoniae from Iraq to France
AAC Accepts, published online ahead of print on 18 January 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.01761-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More information10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP
National Center for Emerging and Zoonotic Infectious Diseases Emerging Resistance Updates Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention and Response Branch
More informationUpdate on CLSI and EUCAST
Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»
More informationNational Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats
National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats Jean B. Patel, PhD, D(ABMM) Science Lead, Antibiotic Resistance and Coordination Unit Centers for
More informationCarbapenemase Producing Organisms. Manal Tadros Medical Microbiologist Fraser Health Authority
Carbapenemase Producing Organisms Manal Tadros Medical Microbiologist Fraser Health Authority 1 Objectives Discuss Laboratory detection of CPO Summarize the Epidemiology of CPO in Fraser Health Authority
More informationNONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN
NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial
More informationCARBAPENEMASE PRODUCING ENTEROBACTERIACEAE
CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE Veroniek Saegeman Veroniek Saegeman UZLeuven Carbapenemase producing Enterobacteriaceae (CPE) Introduction on antibiotic resistance Classification of ß-lactamases
More informationDetection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry
JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.01002-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12
More informationEvaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms
ORIGINAL ARTICLE Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms Julie Creighton and Hui Wang Canterbury Health Laboratories, Christchurch ABSTRACT
More informationPROFESSOR PETER M. HAWKEY
Multi-drug resistant Escherichia coli PROFESSOR PETER M. HAWKEY School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham B15 2TT Health Protection Agency
More informationRapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures
ORIGINAL ARTICLE BACTERIOLOGY Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures L. Dortet 1,L.Brechard 1, L. Poirel 1,2 and P. Nordmann 1,2 1) Service de Bacteriologie-Virologie,
More informationStandardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland
Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland Version 1.0 7 June 2017 Revision Date June 2018 Scottish Microbiology and Virology Network (SMVN) SMVN Standardisation
More informationSpread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory
Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Olga Perovic*, Ashika Singh-Moodley, Samantha Iyaloo 5 th November
More informationEmergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Sophie Vaux, Anne Carbonne, Jean-Michel Thiolet, Vincent Jarlier, Bruno Coignard, the RAISIN and Expert Laboratories Group
More informationOriginal Article Clinical Microbiology
Original Article Clinical Microbiology Ann Lab Med 2015;35:212-219 http://dx.doi.org/10.3343/alm.2015.35.2.212 ISSN 2234-3806 eissn 2234-3814 Combined Use of the Modified Hodge Test and Carbapenemase Inhibition
More informationClin Microbiol Infect Feb;21(2):e11-3. doi: /j.cmi Epub 2014 Oct 29.
This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is posted here by agreement between Elsevier and the University of Turin. Changes resulting from the publishing process
More information(Plasmid mediated) Carbapenemases. Timothy R. Walsh, Cardiff University, Wales
(Plasmid mediated) Carbapenemases Timothy R. Walsh, Cardiff University, Wales What is a carbapenemase? How much carbapenem do they need to breakdown before they are called a carbapenemase? ESBL-enzymes
More informationComparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae
Bartolini et al. Gut Pathogens 2014, 6:13 RESEARCH Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae Andrea Bartolini 1, Ilaria Frasson 2, Antonietta Cavallaro
More informationInfection Control Strategies to Avoid Carbapenam Resistance in Hospitals. Victor Lim International Medical University Malaysia
Infection Control Strategies to Avoid Carbapenam Resistance in Hospitals Victor Lim International Medical University Malaysia Outline of Lecture 1. Carbapenam resistance 2. Epidemiology of carbapenam resistance
More informationPhenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae
ISSN: 2319-7706 Volume 4 Number 6 (2015) pp. 547-552 http://www.ijcmas.com Original Research Article Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae Sathya Pandurangan 1,
More informationIdentification and screening of carbapenemase-producing Enterobacteriaceae
REVIEW 10.1111/j.1469-0691.2012.03815.x Identification and screening of carbapenemase-producing Enterobacteriaceae P. Nordmann 1, M. Gniadkowski 2, C. G. Giske 3, L. Poirel 1, N. Woodford 4, V. Miriagou
More informationEnterobacteriaceae with acquired carbapenemases, 2016
Enterobacteriaceae with acquired carbapenemases, 2016 Background The acquired or transferable (as opposed to chromosomally encoded) carbapenemases found in Enterobacteriaceae belong to three of the four
More informationNavigating Through Current and Emerging Issues in Outbreaks
Navigating Through Current and Emerging Issues in Outbreaks 7th GCC Conference on Infection Prevention and Control December 1-3, 2013 Kuwait City, Kuwait William R. Jarvis, M.D. Jason and Jarvis Associates,
More informationDetecting carbapenemases in Enterobacteriaceae
Detecting carbapenemases in Enterobacteriaceae David Livermore Health Protection Agency, Colindale, London 12 August 2003 Mechanisms of carbapenem R in Enterobacteria Impermeability + AmpC or ESBL Metallo
More informationAcademic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE
Academic Perspective in Emerging No, we can t Issues treat of carbapenemase Resistance and ESBL in Gram-ve producers Bacteria based on MIC David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic
More informationEpidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region
Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region Michael Y. Lin MD MPH 1, Karen Lolans BS 1, Rosie D. Lyles,
More informationARTICLE IN PRESS International Journal of Antimicrobial Agents xxx (2010) xxx xxx
International Journal of Antimicrobial Agents xxx (2010) xxx xxx Contents lists available at ScienceDirect International Journal of Antimicrobial Agents journal homepage: http://www.elsevier.com/locate/ijantimicag
More informationKlebsiella pneumoniae 21 PCR
2011 11 TEM-132 ESBL Klebsiella pneumoniae 1) 2) 1) 1) 3) 2) 1) 2) 3) 19 6 27 22 10 20 2003 4 2004 11 95 ceftazidime (CAZ) Klebsiella pneumoniae 21 PCR b- (ESBL) PCR (PFGE) PCR bla TEM-132 PFGE 19 TEM-132
More informationSensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the
JCM Accepts, published online ahead of print on 20 August 2014 J. Clin. Microbiol. doi:10.1128/jcm.02369-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Sensitivity of Surveillance
More informationReporting blood culture results to clinicians: MIC, resistance mechanisms, both?
Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Christian G. Giske, MD, PhD Senior Consultant Physician/Associate Professor Department of Clinical Microbiology Karolinska
More informationLaboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18
More informationβ- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication
Prevalence of Carbapenem-Hydrolyzing β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication David Alcid M.D Balaji Yegneswaran M.D. Wanpen Numsuwan Introduction Klebsiella pneumoniae
More informationInsert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J
Insert for Kit 98006/98010/98015 KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J DATE OF ISSUE: 09.02.2017 LANGUAGE: English FOR IN VITRO DIAGNOSTIC
More informationCarbapenemase-producing Enterobacteriaceae
Carbapenemase-producing Enterobacteriaceae 2012 CNR Associé Résistance aux Antibiotiques Prof. P. Nordmann Carbapenemases in Enterobacteriaceae May, 2012 Penicillins Cephalosporins Carbapenems Extended-spectrum
More informationRapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann
Rapid identification of emerging resistance in Gram negatives Prof. Patrice Nordmann Emerging Resistance threats, CDC USA-2013 Enterobacteriaceae producing extendedspectrum β-lactamases (ESBL) Multi-resistant
More informationAmerican Journal of Infection Control
American Journal of Infection Control 41 (2013) 190-4 Contents lists available at ScienceDirect American Journal of Infection Control American Journal of Infection Control journal homepage: www.ajicjournal.org
More informationMolecular characterisation of CTX-M-type extendedspectrum β-lactamases of Escherichia coli isolated from a Portuguese University Hospital
EJHP Science Volume 17 2011 Issue 3 P. 1-5 2011 Pharma Publishing and Media Europe. All rights reserved 1781-7595 25 www.ejhp.eu Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of
More informationThe Carbapenemase Producing Enterobacteriaceae (CPE) Epidemic Why it matters? What it is? What Can You Do About It?
The Carbapenemase Producing Enterobacteriaceae (CPE) Epidemic Why it matters? What it is? What Can You Do About It? Martin Cormican National Lead for Health Care Associated Infection and Antimicrobial
More informationCarbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you?
Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you? Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust www.reflectionsipc.com @jonotter Contents What s the problem?
More informationβ CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE
β CARBA Test 25 68260 Rapid detection of carbapenemase-producing Enterobacteriaceae strains 881159 2015/05 Contents 1. INTENDED USE 2. SUMMARY AND EXPLANATION OF THE TEST 3. PRINCIPLE OF THE PROCEDURE
More informationβ-lactamase inhibitors
β-lactamase inhibitors Properties, microbiology & enzymology DAVID M LIVERMORE Professor of Medical Microbiology, UEA Lead on Antibiotic Resistance, Public Health England β-lactamase classes A B C D Serine
More informationPhenotypic detection of ESBLs and carbapenemases
Phenotypic detection of ESBLs and carbapenemases Standardized susceptibility testing residential workshop 2016 Katie Hopkins PhD Clinical Scientist Antimicrobial Resistance and Healthcare Associated Infections
More informationEvaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms
Original Article Clinical Microbiology Ann Lab Med 2017;37:305-312 https://doi.org/10.3343/alm.2017.37.4.305 ISSN 2234-3806 eissn 2234-3814 Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases
More informationA new diagnostic microarray (Check-KPC ESBL) for detection and. identification of extended-spectrum beta-lactamases in highly resistant
JCM Accepts, published online ahead of print on 8 June 2011 J. Clin. Microbiol. doi:10.1128/jcm.02087-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationCarbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan An Infection Control Emergency Speaker: L Kristopher Siu Principal Investigator Division of Infectious Diseases National Institute
More informationSupplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System
Supplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System Supplementary Material and Methods Characterization of isolates by the
More informationAbstract. Introduction. Editor: R. Canton
ORIGINAL ARTICLE BACTERIOLOGY A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry,
More informationHOSPITAL INFECTION CONTROL
HOSPITAL INFECTION CONTROL Objectives To be able to define hospital acquired infections discuss the sources and routes of transmission of infections in a hospital describe methods of prevention and control
More informationMHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions
MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions Dr. Andrew Walkty Medical Microbiologist, Diagnostic Services Manitoba (DSM) June. 17,
More informationTransmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre
ORIGINAL ARTICLE EPIDEMIOLOGY Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre A. Adler 1, M. Gniadkowski 2, A. Baraniak 2, R. Izdebski
More informationContainment of an Outbreak of KPC-3 Carbapenemase-Producing Klebsiella. pneumoniae in Italy
JCM Accepts, published online ahead of print on 7 September 2011 J. Clin. Microbiol. doi:10.1128/jcm.01242-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationEnterobacteriaceae with acquired carbapenemases, 2015
Enterobacteriaceae with acquired carbapenemases, 2015 Background The acquired or transferable (as opposed to chromosomally encoded) carbapenemases found in Enterobacteriaceae belong to three of the four
More informationCRE Laboratory Detection & Recap of ARO Consensus Conference
CRE Laboratory Detection & Recap of ARO Consensus Conference S A S K P I C C O N F E R E N C E S E P T E M B E R 2 6 TH, 2 0 1 4 D R. J E S S I C A M I N I O N, M D M S C F R C P C D(A B M M ) M E D I
More informationSSRG International Journal of Medical Science (SSRG-IJMS) volume 2 Issue 4 April 2015
Utilization of MacConkeyMeropenem screening Agar for the Detection of Carbapenem Resistanant Enterobacteriaceae in a tertiary care hospital Sanjeev Kumar 1, Anamika Vyas 2, S.K.Mehra 3 1,3 Department of
More informationEmergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae ACCEPTED
AAC Accepts, published online ahead of print on 11 June 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.00299-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationAAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac
AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi:10.1128/aac.00931-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions.
More information